Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guerin-infected dendritic cells

European Journal of Immunology

Volumn 29, Issue 6, 1999, Pages 1972-1979

  Demangel, Caroline ^a,b   Bean, Andrew G D ^a,c   Martin, Ela ^a   Feng, Carl G ^a   Kamath, Arun T ^a   Britton, Warwick J ^a,d  

^a CENTENARY INSTITUTE   (Australia)

^b INSTITUT PASTEUR   (France)

^c CSIRO   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dendritic cell; Mycobacterium; Tuberculosis; Vaccination

Indexed keywords

B7 ANTIGEN; BCG VACCINE; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MYCOBACTERIUM ANTIGEN;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BACILLUS; BCG VACCINATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; LUNG INFECTION; MEDIASTINUM LYMPH NODE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

AEROSOLS; ANIMALS; ANTIGEN PRESENTATION; BCG VACCINE; CATTLE; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; RNA, MESSENGER; TRACHEA; TUBERCULOSIS, BOVINE;

EID: 0033023126     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1     Document Type: Article

References (31)

1. Banchereau, J. and Steinman, T. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Cella, M., Sallusto, F. and Lanzavecchia, A., Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997. 9: 10-16.
3. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A., Dendritic cells use macropinocytosis and the man-nose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995. 182: 389-400.
4. Roake, J. A., Rao, A. S., Morris, P. J., Larsen, C. P., Hankins, D. F. and Austyn, J. M., Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 1995. 181: 2237-2247.
5. Xia, W. J., Pinto, C. E. and Kradin, R. L., The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J. Exp. Med 1995. 181: 1275-1283.
6. McWilliam, A. S., Nelson, D., Thomas, J. A. and Holt, P. G., Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surface. J. Exp. Med. 1994. 179: 1331-1336.
7. Steinman, R. M., The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991. 9: 271-296.
8. Inaba, K., Inaba, M., Naito, M. and Steinman, R. M., Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 1993. 178: 479-488.
9. Henderson, R. A., Watkins, S. C. and Flynn, J. L., Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 1997. 159: 635-643.
10. Guzman, C. A., Rhode, M., Bock, M. and Timmis, K. N., Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells. Infect. Immun. 1994. 62: 5528-5537.
11. Su, H., Messer, R., Whitmire, W., Fischer, E., Portis, J. C. and Caldwell, H. D., Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J. Exp. Med. 1998. 188: 809-818.
12. Svensson, M., Stockinger, B. and Wick, M. J., Bone-marrow derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J. Immunol. 1997. 158: 4229-4236.
13. Andersen, P., Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand. J. Immunol. 1997. 45: 115-131.
14. Colditz, G. A., Brewer, T. F., Berkey, C. S., Wilson, M. E., Burdick, E., Fineberg, H. V. and Mosteller, F., Efficacy of BCG vaccine in the prevention of tuberculosis. J. Am. Med. Assoc. 1994. 271: 698-702.
15. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A. and Bloom, B. R., An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993. 178: 2249-2254.
16. Cooper, A. M. and Flynn, J. L., The protective immune response to Mycobacterium tuberculosis. Curr. Opin. Immunol. 1995. 7: 512-516.
17. Ranger, A. M., Das, M. P., Kuchroo, V. K. and Glimcher, L. H., B7-2 (CD86) is essential for the development of IL-4 producing cells. Int. Immunol. 1996. 8: 1549-1560.
18. Subauste, C. S., de Waal Mallefyt, R. and Fuh, F., Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen. J. Immunol. 1998. 160: 831-1840.
19. Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M. and Nussenzweig, M. C., The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995. 375: 151-155.
20. Finkelman, F. D., Lees, A., Birnbaum, R., Gause, W. C. and Morris, S. C., Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 1996. 157: 1406-1414.
21. Vanham, G., Toossi, Z., Hirsch, C. S., Wallis, R. S., Schwander, S. K., Rich, E. A. and Ellner, J. J., Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/ anergy. Tuber. Lung Dis. 1997. 78: 145-158.
22. Denis, M., Interleukin-1 (IL-1) is an important cytokine in granulomatous alveolitis. Cell. Immunol. 1994. 157: 70-80.
23. Huygen, K., Vandenbussche, P. and Heremans, H., Interleukin-6 production in Mycobacterium bovis BCG-infected mice. Cell. Immunol. 1991. 137: 224-231.
24. Yoshida, A., Koide, Y., Uchijima, M. and Yoshida, T. O., Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette Guerin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase. J. Immunol. 1995. 155: 2057-2066.
25. Yoshida, A. and Koide, Y., Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages. Infect. Immun. 1997. 65: 1953-1955.
26. Mackey, M. F., Barth, R. J. Jr. and Noelle, R. J., The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukoc. Biol. 1998. 63: 418-428.
27. Cooper, A. M., Magram, J., Ferrante, J. and Orme, I. M., Interleukin-12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 1997. 186: 39-45.
28. Joseph, S. B., Miner, K. T. and Croft, M., Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur. J. Immunol. 1998. 28: 277-289.
29. Kalinski, P., Schuitemaker, J. H., Hilkens, C. M. and Kapsenberg, M. L., Prostaglandin E2 induces the final maturation of IL-12 deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 1998. 161: 2804-2809.
30. Kamath, A. T., Feng, C. G., Macdonald, M., Briscoe, H. and Britton, W. J., Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun. 1999. 67: 1702-1707.
31. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse BM cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.